Mayeaux E J, Johnson C
Department of Family Medicine, Lousiana State University Medical Center, Shreveport, USA.
J Fam Pract. 1996 Jul;43(1):69-75.
As more women are living longer, there is an increasing need for women to discuss hormone replacement therapy (HRT) with their physicians. This task is complicated by areas of scientific uncertainty and evolving data concerning the risks and benefits of HRT. Benefits of HRT that are supported by strong scientific evidence include relief from menopausal symptoms such as hot flashes, prevention of osteoporosis, cardioprotective effects, relief of urogenital atrophy, and decreased urinary incontinence. Benefits supported by observational evidence include improvement of emotional lability and depression, improved sense of well-being in patients with rheumatoid arthritis, increased dermal and total skin thickness, improved verbal memory skills, and decreased risk of colon cancer. Risks to consider include a possible increase in the incidence of breast cancer and an increase in endometrial cancer in women who have an intact uterus and do not receive a progestin. Women in various risk groups, such as those at risk for coronary artery disease, osteoporosis, or breast cancer, must consider the risk-to-benefit ratio for their own individual circumstances.
随着越来越多的女性寿命延长,女性与医生讨论激素替代疗法(HRT)的需求日益增加。由于科学上存在不确定性以及有关HRT风险和益处的数据不断演变,这项任务变得复杂。有充分科学证据支持的HRT益处包括缓解潮热等更年期症状、预防骨质疏松症、心脏保护作用、缓解泌尿生殖系统萎缩以及减少尿失禁。观察性证据支持的益处包括改善情绪不稳定和抑郁、改善类风湿性关节炎患者的幸福感、增加皮肤真皮层和总皮肤厚度、提高言语记忆能力以及降低结肠癌风险。需要考虑的风险包括乳腺癌发病率可能增加,以及子宫完整且未接受孕激素治疗的女性子宫内膜癌发病率增加。处于各种风险组的女性,如患有冠状动脉疾病、骨质疏松症或乳腺癌风险的女性,必须根据自身情况考虑风险效益比。